Real-world Experience in Treatment of Donor-Derived Hepatitis C Virus in Kidney Transplant Recipients with Delayed Initiation, Shortened Course Glecaprevir/pibrentasvir Versus Standard of Care.
TRANSPLANT INFECTIOUS DISEASE（2024）
Key words
direct-acting antiviral agents,infectious,hepatitis C,kidney disease,kidney transplantation,sustained virologic response,viral
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined